Commercialization


  • Image attribution tooltip
    George Marks via Getty Images

    PBMs under fire for drug prices defend their worth

    A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.

    By May 26, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Ironwood Pharmaceuticals is charting a course to become a giant in GI

    Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

    By May 19, 2022
  • Image attribution tooltip
    John Moore via Getty Images

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • Image attribution tooltip
    iStock via Getty Images

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By May 11, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

    With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

    By May 9, 2022
  • Image attribution tooltip

    Adobe Stock / Song about summer

    Sponsored by EVERSANA

    Right-sizing the channel strategy for maximum impact

    Failure to right-size your distribution model imposes financial penalties and wasted expenditures.

    May 9, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By May 5, 2022
  • Image attribution tooltip
    Stock via Getty Images

    From the fringes to the forefront — the mRNA era has taken hold of pharma

    A look at what’s next for the industry’s buzziest technology.

    By Kim Ribbink • April 22, 2022
  • Image attribution tooltip

    Permission granted by Ted Love. 

    Profile

    For Global Blood Therapeutics, the connection to sickle cell disease runs deep

    An underserved patient population is a guiding light for the company, which recently scored a new approval.

    By Robin Robinson • April 19, 2022
  • Image attribution tooltip
    Justin Sullivan / Staff via Getty Images
    Q&A

    How pharma can up its social media game

    Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities. 

    By April 18, 2022
  • Image attribution tooltip
    Win McNamee/Staff via Getty Images

    How Congress could play a role in personalized medicine

    PGx — a tool to help determine proper dosing — may be poised to achieve broader use in healthcare and pharma.

    By Kelly Bilodeau • April 11, 2022
  • Image attribution tooltip
    Ilya Lukichev via Getty Images

    Optinose CEO senses big opportunities for the company's nasal delivery device

    Peter Miller explains how a repackaged sinus drug has won late-stage clinical success.

    By Jared Whitlock • April 11, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Time-saving tech lights Alcon's path into digital innovation

    Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

    By Kim Ribbink • April 4, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

    The CEO is setting a path to transform women’s health at an opportune time.

    By March 30, 2022
  • Image attribution tooltip

    Permission granted by Alloy.

    Profile

    From media to menopause: Creating new spaces in women's telehealth

    Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

    By Alexandra Pecci • March 29, 2022
  • Image attribution tooltip

    Permission granted by Steve Leber.

    How a rock 'n' roll guru is putting a new spin on health education for patients

    A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.

    By March 28, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Why Astellas is adopting a 'focus area approach' to partnerships

    Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.

    By Kim Ribbink • March 22, 2022
  • Image attribution tooltip

    Permission granted by Anthony Mack.

    Virpax's CEO on leveraging new formulations to move drugs toward approval

    Anthony Mack shares his lessons from getting unconventional pharma products across the finish line.

    By March 18, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Ceek Women's Health CEO Fahti Khosrowshahi

    Fahti Khosrowshahi, CEO and founder, Ceek Women’s Health, is designing award-winning products to change the face of women's health. 

    By March 16, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Liquid biopsy is a multibillion-dollar market, and InterVenn is looking to take advantage

    The company’s CEO explains how its liquid biopsy tests target a unique, untapped layer of biology.

    By March 14, 2022
  • Image attribution tooltip

    Permission granted by Russell Potterfield.

    Profile

    From angel to operator: The unlikely journey of Endevica Bio's CEO

    Russell Potterfield is honing his new found passion for the space to guide Endevica into the clinic.

    By Jared Whitlock • March 9, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo

    Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.

    By Feb. 23, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Eisai's mission to shake off Aduhelm's shadow and bring another AD drug to market

    The company's senior VP of clinical research on how they're building off the science of Aduhelm to develop better Alzheimer's treatments.

    By Kelly Bilodeau • Feb. 23, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Organon's Chief Commercial Officer Susanne Fiedler

    Susi Fiedler, chief commercial officer, was instrumental in the spinout of Organon as a standalone company focused on a broad range of women’s health issues.

    By Feb. 16, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Profile

    How Veru is developing blockbuster drugs while avoiding biotech's 'valley of death'

    Why sexual health and telemedicine are key to the company's goals in oncology.

    By Feb. 16, 2022